In vivo labeling of angiotensin II receptors with a carbon-11-labeled selective nonpeptide antagonist

Journal of Nuclear Medicine

Volumn 37, Issue 2, 1996, Pages 307-311

  Kim, Sang Eun ^b   Scheffel, Ursula ^a   Szabo, Zsolt ^b   Burns, H Donald ^b   Gibson, Raymond E ^b   Ravert, Hayden T ^b   Mathews, William B ^b   Hamill, Terence G ^b   Dannals, Robert F ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

angiotensin II receptors; carbon 11 L 159,884; PET

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CARBON 11; DL PROPANOLOL; L 159689; L 159884; L 159913; L 162914; N [[4' [(2 ETHYL 5,7 DIMETHYL 3H IMIDAZO[4,5 B]PYRIDIN 3 YL)METHYL] 2 BIPHENYLYL]SULFONYL]BENZAMIDE; PRAZOSIN; PROPRANOLOL; UNCLASSIFIED DRUG; YOHIMBINE;

ARTICLE; BINDING AFFINITY; CALCULATION; DRUG DISTRIBUTION; DRUG DOSE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; STATISTICAL ANALYSIS; TISSUE DISTRIBUTION;

ANIMALS; CARBON RADIOISOTOPES; EVALUATION STUDIES; HEART; IMIDAZOLES; KIDNEY; LUNG; MALE; MICE; MICE, INBRED STRAINS; PYRIDINES; RECEPTORS, ANGIOTENSIN; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 9344245114     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Sealey JE, Laragh JH. The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. In. Laragh JH, Brenner BM, eds Hypertension pathophysiology, diagnosis and management New York. Raven Press; 1990:1287-1317.
2. Vallotton MB. The renin-angiotensin system Trends Pharmacol Sci 1987;8 69-74.
3. Marsden PA, Brenner BM, Ballermann BJ Mechanisms of angiotensin action on vascular smooth muscle, the adrenal and the kidney. In: Laragh JH, Brenner BM, eds Hypertension pathophysiology, diagnosis and management. New York: Raven Press; 1990 1247-1272
4. Timmermans PB, Wong PC, Chiu AT, et al Angiotensin II receptors and angiotensin II receptor antagonists Pharmacol Rev 1993,45:205-251
5. Entzeroth M, Hadamovsky S. Angiotensin II receptors in the rat lung are of the AII-1 subtype Eur J Pharmacol 1991;206:237-241.
6. Peach MJ, Chiu AT. Stimulation and inhibition of aldosterone biosynthesis in vitro by angiotensin II and analogs. Circ Res 1974;1(suppl 1):34-35.
7. Duncia JV, Carini DJ, Chiu AT, et al. The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist. Med Res Rev 1992;12:149-191.
8. Blankley CJ, Hodges JC, Klutchko SR, et al Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. J Med Chem 1991;34:3248-3260.
9. Chang RS, Lotti VJ. Selective ligands reveal subtypes of angiotensin receptors in rat vasculatures and brain [Abstract] Pharmacologist 1989;31.150.
10. Chiu AT, Herblin WF, McCall DE, et al. Identification of angiotensin II receptor subtypes Biochem Biophys Res Commun 1989,165 196-203.
11. Whitebread S, Mele M, Kamber B, de Gasparo M Preliminary biochemical characterization of two angiotensin II receptor subtypes Biochem Biophys Res Commun 1989;163 284-291.
12. Chang RS, Lotti VJ. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands. Mol Pharmacol 1990,37:347-351.
13. Wong PC, Price WA, Chiu AT, et al Nonpeptide angiotensin II receptor antagonists XI. Pharmacology of EXP3174, an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990,255:211-217
14. Bumpus FM, Catt KJ, Chiu AT, et al. Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension 1991.17 720-721
15. 1 receptor imaging. Appl Radiat Isot Int J Rad Appl Instrum [A] 1995: in press.
16. 11C-carfentanil. Int J Appl Radiat Isot 1985;36:303-306.
17. Bylund DB Analysis of receptor binding data In: Receptor binding techniques. Cincinnati, OH: Society for Neuroscience: 1980;70-79.
18. 125I]RT1-55 to dopamine transporters: pharmacology and regional distribution with autoradiography. Synapse 1992;12:37-46.
19. Beauchamp HT, Chang RSL, Siegl PKS, and Gibson RE In vivo receptor occupancy of the angiotensin II receptor by nonpeptide antagonists: relationship to in vitro affinities and in vivo pharmacological potency. J Pharmacol Exp Ther 1995; 272:612-618.
20. Timmermans PB, Wong PC, Chiu AT, Herblin WF. Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol Sci 1991.12:55-62.
21. Smith RD, Chiu AT, Wong PC, Herblin WF, Timmermans PB. Pharmacology of nonpeptide angiotensin II receptor antagonists Annu Rev Pharmacol Toxicol 1992; 32:135-165.
22. Chiu AT, Herblin WF, McCall DE, et al. Identification of angiotensin II receptor subtypes Biochem Biophys Res Commun 1989,165.196-203
23. Sasaki K, Yamano Y, Bardhan S, et al. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 1991;351:230-233.
24. McQueen J, Semple PF Angiotensin receptor assay and charaterization In: Conn PM, ed. Methods in neurosci. San Diego: Academic Press; 1991:312-330.
25. Chang RS, Siegl PK, Clineschmidt BV, et al. In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist J Pharmacol Exp Ther 1992;262:133-138.
26. Siegl PK, Chang RS, Mantlo NB et al. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist. J Pharmacol Exp Ther 1992;262:139-144
27. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A. Angiotensin II receptors in normal and failing human hearts J Clin Endocrinol Metab 1989.69 54-66.
28. Allen AM, Yamada H. Mendelsohn FA In vitro autoradiographic localization of binding to angiotensin receptors in the rat heart Jnt J Cardiol 1990;28 25-33
29. Leung KH, Smith RD, Timmermans PB, Chiu AT. Regional distribution of the two subtypes of angiotensin II receptor in rat brain using selective nonpeptide antagonists Neurosci Lett 1991;123:95-98.
30. Wamsley JK, Herblin WF, Alburges ME, Hunt M. Evidence for the presence of angiotensin II-type 1 receptors in brain Brain Res Bull 1990,25.397-400
31. Song K, Allen AM, Paxinos G, Mendelsohn FA Mapping of angiotensin II receptor subtype heterogeneity in rat brain J Comp Neurol 1992;316 467-484
32. Aldred GP, Chai SY, Song K, Zhuo J, MacGregor DP, Mendelsohn FA. Distribution of angiotensin II receptor subtypes in the rabbit brain Regul Pept 1993;44.119-130
33. Barnes JM, Barber PC, Barnes NM Identification of angiotensin II receptor subtypes in human brain Neuroreport 1991;2 605-608.
34. Dudley DT, Panek RL, Major TC, et al Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol 1990;38.370-377
35. de Gasparo M, Whitebread S, Mele M, et al. Biochemical characterization of two angiotensin II receptor subtypes in the rat. J Cardiovasc Pharmacol 1990;16(suppl 4):S31-S35.
36. Kao PF, Szabo Z, Dannals RF, et al Compartmental modeling of an angiotensin II/AT1 receptor imaging agent: carbon-11 L-159,884 [Abstract]. J Nucl Med 1994; 35:137P
37. Yoshida H, Kakuchi J, Guo DF, et al. Analysis of the evolution of angiotensin II type 1 receptor gene in mammals (mouse, rat, bovine and human). Biochem Biophys Res Commun 1992;186:1042-1049.
38. Sasamura H, Hein L, Krieger JE, Pratt RE, Kobilka BK, Dzau VJ. Cloning, characterization and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun 1992,185:253-259.
39. Kakar SS, Sellers JC, Devor DC, Musgrove LC, Neill JD. Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation Biochem Biophys Res Commun 1992.183:1090-1096.
40. Sandberg K, Ji H, Clark AJ, Shapira H, Catt KJ. Cloning and expression of a novel angiotensin II receptor subtype. J Biol Chem 1992,267.9455-9458